Aurora Spine Completes IPO, Earns $3.61M for Lumbar Fusion Device Development

Carlsbad, Calif.-based Aurora Spine has completed its initial public offering of 5.15 million shares at $0.70 per share for approximately $3.61 million in proceeds.

Advertisement

The majority of the proceeds will go toward the development, testing and launch of the company’s second lumbar fusion device.

Aurora Spine is now public on the TSX Venture Exchange.

More Articles on Devices:
Southern Spine’s C-Fuse Intervertebral Fusion System Receives FDA 510(k) Approval   
Flower Orthopedics Makes FlowerCube Available
Medtronic Center of Excellence Opens in Singapore

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.